EUVIMEDEUVIMED entdecken
Crossref

Successful Osimertinib Rechallenge Under Systemic Corticosteroid Administration in EGFR T790M-positive Lung Adenocarcinoma After Osimertinib-induced Interstitial Lung Disease

Mikako Tsuruta, Yasuhiro Nakashima, Kei Aoyagi, Ryusaku Hosoya, Takahiro Ando, Atsushi Nakagawa, Midori Wakiya, Chika Noguchi

Haigan · 20.04.2026 · 66 (2) · 60-65

DOI: 10.2482/haigan.66.60 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Haigan, erschienen am 20.04.2026. Verfasst von Mikako Tsuruta und 7 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Tsuruta, M., Nakashima, Y., Aoyagi, K., Hosoya, R., Ando, T., Nakagawa, A., Wakiya, M., & Noguchi, C. (2026). Successful Osimertinib Rechallenge Under Systemic Corticosteroid Administration in EGFR T790M-positive Lung Adenocarcinoma After Osimertinib-induced Interstitial Lung Disease. Haigan, 66(2), 60-65. https://doi.org/10.2482/haigan.66.60

Vancouver

Tsuruta M, Nakashima Y, Aoyagi K, Hosoya R, Ando T, Nakagawa A, et al. Successful Osimertinib Rechallenge Under Systemic Corticosteroid Administration in EGFR T790M-positive Lung Adenocarcinoma After Osimertinib-induced Interstitial Lung Disease. Haigan. 2026;66(2):60-65. doi:10.2482/haigan.66.60

BibTeX
@article{Tsuruta2026,
  author = {Tsuruta, Mikako and Nakashima, Yasuhiro and Aoyagi, Kei and Hosoya, Ryusaku and Ando, Takahiro and Nakagawa, Atsushi and Wakiya, Midori and Noguchi, Chika},
  title = {Successful Osimertinib Rechallenge Under Systemic Corticosteroid Administration in EGFR T790M-positive Lung Adenocarcinoma After Osimertinib-induced Interstitial Lung Disease},
  journal = {Haigan},
  year = {2026},
  volume = {66},
  number = {2},
  pages = {60--65},
  doi = {10.2482/haigan.66.60}
}
Kostenlos starten →